CML is a clonal disorder of pluripotent hematopoietic cells, characterized by the presence of a gene, BCR-ABL, that encodes a constitutively active tyrosine kinase fusion protein [149]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.